drugset / Trial / NCT07651475
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy and safety of the Beach regimen on relapsed/refractory acute myeloid leukemia
Timeline
- Start
- 2026-03-31
- Primary completion
- 2026-03-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Tucidinostat | Small molecule | — | — |
| Subject | Zemestosita | Unknown | — | — |